Haemonetics (HAE -0.4%) says its proposed acquisition of Hemerus Medical will likely be put off...

|About: Haemonetics Corp (HAE)|By:, SA News Editor

Haemonetics (HAE -0.4%) says its proposed acquisition of Hemerus Medical will likely be put off until next March after the start of its 2014 fiscal year. The company notes that U.S. regulators are asking for more information about its SOLX whole-blood collection system as part of a resubmitted marketing application.